Rubella Antibody Blood Test (Rubella IgM)

Rubella, also known as German measles, is a viral infection that is usually mild in children and adults but can cause serious harm to an unborn baby if a woman becomes infected during early pregnancy. This test detects IgM antibodies against the rubella virus, which typically appear early in the course of infection and indicate a recent or current infection. It is used to investigate suspected acute rubella, to assess possible exposure in pregnant women or those planning pregnancy, and to support public health surveillance and outbreak control. It may also be requested for individuals who have symptoms consistent with rubella, such as a rash, fever, and swollen glands, or who have had close contact with a confirmed case.

The test measures the following marker:

Rubella Serology
- Rubella IgM: Detects IgM-class antibodies produced by the immune system shortly after infection with the rubella virus. A positive result suggests recent infection or exposure, while a negative result makes recent infection less likely, though timing of the sample can affect interpretation.

Why it matters
Rubella infection during pregnancy, especially in the first trimester, can lead to miscarriage, stillbirth, or congenital rubella syndrome, which may cause deafness, cataracts, heart defects, and developmental problems in the baby. Identifying recent infection promptly allows healthcare professionals to provide appropriate advice, arrange further assessment, and take steps to protect vulnerable individuals. For anyone concerned about rubella exposure or symptoms, this test offers a clear and reliable way to establish whether recent infection has occurred.